Suchergebnisse - "Lopinavir"

PubPharm (3.163)

141

Optimal Drug Regimen and Combined Drug Therapy and Its Efficacy in the Treatment of COVID-19: A Within-Host Modeling Study

enthalten in: Acta biotheoretica | 2022

von Chhetri, B. | Bhagat, V. | Vamsi, D. | +5

142

Effects of Drugs Formerly Suggested for COVID-19 Repurposing on Pannexin1 Channels

enthalten in: International journal of molecular sciences | 2022

von Caufriez, A. | Tabernilla, A. | Van Campenhout, R. | +8

143

Letter to the Editor : Pharmacokinetics of Lopinavir/Ritonavir in Hospitalized Patients with COVID-19 Not Requiring Critical Care

enthalten in: Microbial drug resistance (Larchmont, N.Y.) | 2022

von MacGowan, A. | Hamilton, F. | Bayliss, M. | +8

CommentOn: Ann Intern Med. 2020 Oct 20;173(8):670-672. - PMID 32422065

144

COVID-19 and the promise of small molecule therapeutics : Are there lessons to be learnt?

enthalten in: Pharmacological research | 2022

von Ho, W. | Zhang, R. | Tan, Y. | +1

145

Slower Recovery with Early Lopinavir/Ritonavir use in Pediatric COVID-19 Patients : A Retrospective Observational Study

enthalten in: Paediatric drugs | 2022

von Wong, C. | Low, M. | Kwok, A. | +8

146

Quality of life and associated factors among people receiving second-line anti-retroviral therapy in Johannesburg, South Africa

enthalten in: BMC infectious diseases | 2022

von Mokgethi, N. | Christofides, N. | Machisa, M. | +2

147

Agreement of treatment effects from observational studies and randomized controlled trials evaluating hydroxychloroquine, lopinavir-ritonavir, or dexamethasone for covid-19 : meta-epidemiological study

enthalten in: BMJ (Clinical research ed.) | 2022

von Moneer, O. | Daly, G. | Skydel, J. | +4

148

Combination of QSAR, molecular docking, molecular dynamic simulation and MM-PBSA : analogues of lopinavir and favipiravir as potential drug candidates against COVID-19

enthalten in: Journal of biomolecular structure & dynamics | 2022

von Rafi, M. | Bhattacharje, G. | Al-Khafaji, K. | +5

149

Hospital compounding to face shortage : A case study of the development of a lopinavir-ritonavir oral suspension during the first wave of SARS-COV-2 in France

enthalten in: Annales pharmaceutiques francaises | 2022

von Secretan, P. | Thirion, O. | Vieillard, V. | +4

150

Effects of Drugs Formerly Proposed for COVID-19 Treatment on Connexin43 Hemichannels

enthalten in: International journal of molecular sciences | 2022

von Cooreman, A. | Caufriez, A. | Tabernilla, A. | +7